This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Partnerships In Clinical Trials Nominates Christine Pierre For Clinical Trial Business Woman Of The Year

ROCKVILLE, Md., April 10, 2013 /PRNewswire/ -- The Society for Clinical Research Sites (SCRS) is pleased to announce that President Christine Pierre has been nominated for the Clinical Trial Business Woman of the Year Award.  This prestigious award, granted by the Partnerships in Clinical Trials (PCT), recognizes a woman who has exemplified strong and innovative leadership and has set an example to other women in the clinical trials industry on a global scale.  It will be presented as part of the upcoming Partnerships in Clinical Trials conference, which will take place April 21 - 24 in Orlando, Florida.  The winner will be chosen by the PCT Advisory Board members, made up of executives across the clinical trial landscape including sponsors, contract research organizations (CROs), and industry consultant experts.  

"This is truly an honor, not only to be nominated by my esteemed colleagues, but also because this nomination indicates that sites are truly being recognized for their contribution to the research ecosystem.  I have always worked from a position of passion and not recognition, however, it is wonderful to have this work acknowledged because it gives validity to the sites, their voice and collective influence," says Ms. Pierre.

In October 2012, at the Site Solutions Summit, an annual gathering of clinical trial stakeholders, Ms. Pierre announced the formation of SCRS, a trade association dedicated to providing a voice and community to clinical research sites across the globe.  As an SCRS representative, she has been appointed to the Board of the Metrics Champion Consortium (MCC), a global non-profit organization that develops standardized performance metrics for the clinical trials industry.  She is also a member of the Steering Committee of the Clinical Trials Transformation Initiative (CTTI), and a member of the Board of Advisors for both the Center for Information and Study on Clinical Research Participation (CISCRP) and Hands Across the Americas.

Ms. Pierre is internationally known for her expertise in clinical research site management and patient recruitment and retention in the clinical trials industry.  In this capacity, she is a frequent guest speaker at industry conferences, having addressed audiences in the United States and around the globe.

About SCRSSCRS is a trade organization representing global clinical research sites. SCRS' mission is to unify and amplify the voice of the global clinical research site community.  SCRS has become an active partner in industry-wide dialogues focused on improving the clinical research enterprise among the many industry initiatives.  Sites, as well as companies that sponsor or support the work conducted at the clinical research sites, will benefit from membership.  Visit

SOURCE Society for Clinical Research Sites

Copyright 2011 PR Newswire. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free


Chart of I:DJI
DOW 17,050.75 +138.46 0.82%
S&P 500 1,995.83 +15.91 0.80%
NASDAQ 4,810.7880 +19.6360 0.41%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs